Bohjanen, Kimberly A <br/><br/>
New biologic therapies for psoriatic disease.  [electronic resource] 

 -  Minnesota medicine  Mar 2004 
 - 34-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0026-556X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alefacept<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Clinical Trials as Topic<br/>Etanercept<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Immunologic Factors--adverse effects<br/>Immunosuppressive Agents--adverse effects<br/>Infliximab<br/>Psoriasis--immunology<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Recombinant Fusion Proteins--adverse effects<br/>T-Lymphocytes--drug effects<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors